MTOR and cancer: Negative feedback regulation in PI3K-mediated cells through the insulin receptor substrate20 and relatively weak pathway activation in PIK3CA-mutated cancers have also been suggested as possible explanations for low levels of signaling through mTOR in ER-positive BC.